Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors.

International journal of pharmaceutics

Volumn 456, Issue 1, 2013, Pages 202-211

  Buckway, Brandon ^a   Wang, Yongjian ^b   Ray, Abhijit ^b   Ghandehari, Hamidreza ^b  

^a UNIVERSITY OF UTAH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; OLIGOPEPTIDE; POLYMER; VITRONECTIN RECEPTOR;

ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PANCREAS TUMOR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; INTEGRIN ALPHAVBETA3; MICE; MICE, NUDE; OLIGOPEPTIDES; PANCREATIC NEOPLASMS; POLYMERS; RECEPTOR, ERBB-2;

EID: 84899043468     PISSN: None     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.07.067     Document Type: Article

References (53)

1. American Cancer Society, Cancer Facts and Figures 2012. American Cancer Society. Atlanta, GA.
2. Bailey 2005,D.L. Bailey Positron Emission Tomography: Basic Sciences Springer, New York (2005)
3. Baxter L.T.,Jain R.K.Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection.Microvascular Research 37(1),1989,pp:77-104.
4. M.P. Borgman, O. Aras, S. Geyser-Stoops, E.A. Sausville, H. Ghandehari Biodistribution of HPMA copolymer–aminohexylgeldanamycin–RGDfK conjugates for prostate cancer drug delivery.Molecular Pharmaceutics, 6(6),2009,pp. 1836-1847
5. M.P. Borgman, T. Coleman, R.B. Kolhatkar, S. Geyser-Stoops, B.R. Line, H. Ghandehari.Tumor-targeted HPMA copolymer–(RGDfK)–(CHX-A-DTPA) conjugates show increased kidney accumulation.Journal of Controlled Release, 132(3), (2008), pp. 193-199
6. Y. Boucher, L.T. Baxter, R.K. Jain.Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy.Cancer Research 50(15),(1990), pp. 4478-4484
7. Y. Boucher, R.K. Jain.Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse.Cancer Research, 52(18),(1992), pp. 5110-5114
8. C. Brekken, C. de Lange Davies.Hyaluronidase reduces the interstitial fluid pressure in solid tumours in a non-linear concentration-dependent manner.Cancer Letters, 131(11),(1998), pp. 65-70
9. P.J. Brennan, T. Kumagai, A. Berezov, R. Murali, M.I. Greene.HER2/neu: mechanisms of dimerization/oligomerization.Oncogene, 19(53),(2000), pp. 6093-6101
10. C. Cayrol, C. Bertrand, A. Kowalski-Chauvel, L. Daulhac, E. Cohen-Jonathan-Moyal, A. Ferrand, C. Seva.Alphav integrin: a new gastrin target in human pancreatic cancer cells.World Journal of Gastroenterology, 17(40),(2011), pp. 4488-4495
11. G. Feldmann, V. Fendrich, K. McGovern, D. Bedja, S. Bisht, H. Alvarez, J.B. Koorstra, N. Habbe, C. Karikari, M. Mullendore, K.L. Gabrielson, R. Sharma, W. Matsui, A. Maitra.An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.Mol. Cancer Ther., 7 (2008), pp. 2725-2735
12. K. Garber.Stromal depletion goes on trial in pancreatic cancer.Journal of the National Cancer Institute, 102(7),(2010), pp. 448-450
13. K. Greish, A. Ray, H. Bauer, N. Larson, A. Malugin, D. Pike, M. Haider, H. Ghandehari.Anticancer and antiangiogenic activity of HPMA copolymer–aminohexylgeldanamycin–RGDfK conjugates for prostate cancer therapy.Journal of Controlled Release, 151(3),2011, pp. 263-270
14. M.M. Herth, M. Barz, M. Jahn, R. Zentel, F. Rosch.72/74As-labeling of HPMA based polymers for long-term in vivo PET imaging.Bioorganic and Medicinal Chemistry Letters 20(18),2010.pp. 5454-5458
15. M.M. Herth, M. Barz, D. Moderegger, M. Allmeroth, M. Jahn, O. Thews, R. Zentel, F. Rosch.Radioactive labeling of defined HPMA-based polymeric structures using [18F]FETos for in vivo imaging by positron emission tomography.Biomacromolecules, 10(7),2009, pp. 1697-1703
16. M. Hidalgo.Pancreatic cancer.N. Engl. J. Med., 362 (2010), pp. 1605-1617
17. M. Hidalgo.New insights into pancreatic cancer biology.Ann. Oncol., 23 (2012), pp. x135-x138
18. R. Hosotani, M. Kawaguchi, T. Masui, T. Koshiba, J. Ida, K. Fujimoto, M. Wada, R. Doi, M. Imamura.Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis.Nursing, 25 (2),2002, pp. e30-e35
19. Z.Q. Huang, D.J. Buchsbaum.Monoclonal antibodies in the treatment of pancreatic cancer.Immunotherapy, 1 (2009), pp. 223-229
20. M.A. Jacobetz, D.S. Chan, A. Neesse, T.E. Bapiro, N. Cook, K.K. Frese, C. Feig, T. Nakagawa, M.E. Caldwell, H.I. Zecchini, M.P. Lolkema, P. Jiang, A. Kultti, C.B. Thompson, D.C. Maneval, D.I. Jodrell, G.I. Frost, H.M. Shepard, J.N. Skepper, D.A. Tuveson.Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer.Gut, 62 (2013), pp. 112-120
21. N.G. Karasseva, V.V. Glinsky, N.X. Chen, R. Komatireddy, T.P. Quinn.Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library.Journal of Protein Chemistry , 21(4),2002, pp. 287-296
22. K. Kimura, T. Sawada, M. Komatsu, M. Inoue, K. Muguruma, T. Nishihara, Y. Yamashita, N. Yamada, M. Ohira, K. Hirakawa.Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabine.Clin. Cancer Res., 12 (2006), pp. 4925-4932
23. M. Komoto, B. Nakata, R. Amano, N. Yamada, M. Yashiro, M. Ohira, K. Wakasa, K. Hirakawa.HER2 overexpression correlates with survival after curative resection of pancreatic cancer.Cancer Science., 100(7),2009, pp. 1243-1247
24. J. Kopecek.Polymer–drug conjugates: origins, progress to date and future directions.Advanced Drug Delivery Reviews., 65(1),2013, pp. 49-59
25. J. Kopecek, P. Kopeckova.HPMA copolymers: origins, early developments, present, and future.Advanced Drug Delivery Reviews, 62(2) (2010), pp. 122-149
26. J. Kopecek, P. Kopeckova, T. Minko, Z.R. Lu, C.M. Peterson.Water soluble polymers in tumor targeted delivery.J. Controlled Release, 74 (2001), pp. 147-158
27. M. Korc.Pathways for aberrant angiogenesis in pancreatic cancer.Mol. Cancer, 2 (2003), pp. 1-8
28. K. Luo, J. Yang, P. Kopeckova, J. Kopecek.Biodegradable multiblock poly[N-2-hydroxypropyl)methacrylamide] via reversible addition–fragmentation chain transfer polymerization and click chemistry.Macromolecules, 44(8),(2011), pp. 2481-2488
29. H.R. Maecke, A. Riesen, W. Ritter.The molecular structure of indium-DTPA.Journal of Nuclear Medicine 30(7),(1989), pp. 1235-1239
30. S. Marchan, S. Perez-Torras, A. Vidal, J. Adan, F. Mitjans, N. Carbo, A. Mazo.Dual effects of beta3 integrin subunit expression on human pancreatic cancer models.Cellular Oncology, 34(4),2011, pp. 393-405
31. E.E. Merika, K.N. Syrigos, M.W. Saif.Desmoplasia in pancreatic cancer: can we fight it?Gastroenterology research and practice, 2012 (2012)
32. P. Michl, T.M. Gress.Improving drug delivery to pancreatic cancer: breaching the stromal fortress by targeting hyaluronic acid.Gut, 61 (2012), pp. 1377-1379
33. A. Mitra, T. Coleman, M. Borgman, A. Nan, H. Ghandehari, B.R. Line.Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting.Journal of Controlled Release, 114(2),(2006), pp. 175-183
34. A. Mitra, A. Nan, J.C. Papadimitriou, H. Ghandehari, B.R. Line.Polymer–peptide conjugates for angiogenesis targeted tumor radiotherapy.Nuclear Medicine and Biology., 33(1) (2006), pp. 43-52
35. A. Neesse, P. Michl, K.K. Frese, C. Feig, N. Cook, M.A. Jacobetz, M.P. Lolkema, M. Buchholz, K.P. Olive, T.M. Gress, D.A. Tuveson.Stromal biology and therapy in pancreatic cancerGut, 60 (2011), pp. 861-868
36. Y. Noguchi, J. Wu, R. Duncan, J. Strohalm, K. Ulbrich, T. Akaike, H. Maed Early phase tumor accumulation of macromolecules: a great difference in clearance rate between tumor and normal tissues Jpn. J. Cancer Res., 89 (1998), pp. 307-314
37. L.J. Nugent, R.K. Jain.Plasma pharmacokinetics and interstitial diffusion of macromolecules in a capillary bed.American Journal of Physiology - Heart and Circulatory Physiology., 15(1), (1984)
38. K.P. Olive, M.A. Jacobetz, C.J. Davidson, A. Gopinathan, D. McIntyre, D. Honess, B. Madhu, M.A. Goldgraben, M.E. Caldwell, D. Allard, K.K. Frese, G. Denicola, C. Feig, C. Combs, S.P. Winter, H. Ireland-Zecchini, S. Reichelt, W.J. Howat, A. Chang, M. Dhara, L. Wang, F. Ruckert, R. Grutzmann, C. Pilarsky, K. Izeradjene, S.R. Hingorani, P. Huang, S.E. Davies, W. Plunkett, M. Egorin, R.H. Hruban, N. Whitebread, K. McGovern, J. Adams, C. Iacobuzio-Donahue, J. Griffiths, D.A. Tuveson.Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.Science, 324 (2009), pp. 1457-1461
39. D.B. Pike, H. Ghandehari.HPMA copolymer–cyclic RGD conjugates for tumor targeting.Advanced Drug Delivery Reviews., 62(2),(2010), pp. 167-183
40. P.P. Provenzano, C. Cuevas, A.E. Chang, V.K. Goel, D.D. Von Hoff, S.R. Hingorani.Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma.Cancer Cell, 21(3),(2012), pp. 418-429
41. A. Ray, N. Larson, D.B. Pike, M. Gruner, S. Naik, H. Bauer, A. Malugin, K. Greish, H. Ghandehari.Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer–RGDfK conjugates.Mol. Pharm., 8 (2011), pp. 1090-1099
42. H. Safran, D. Iannitti, R. Ramanathan, J.D. Schwartz, M. Steinhoff, C. Nauman, P. Hesketh, R. Rathore, R. Wolff, U. Tantravahi, T.M. Hughes, C. Maia, T. Pasquariello, L. Goldstein, T. King, J.Y. Tsai, T. Kennedy.Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.Cancer Invest., 22 (2004), pp. 706-712
43. H. Safran, M. Steinhoff, S. Mangray, R. Rathore, T.C. King, L. Chai, K. Berzein, T. Moore, D. Iannitti, P. Reiss, T. Pasquariello, P. Akerman, D. Quirk, R. Mass, L. Goldstein, U. Tantravahi.Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.Am. J. Clin. Oncol., 24 (2001), pp. 496-499
44. J. Strohalm,J.Kopecek.Poly N-(2-hydroxypropyl) methacrylamide: 4. Heterogenous polymerization.Die Angewandte Makromolekulare Chemie., 70(1)(1978), pp. 109-118
45. T. Stylianopoulos, C. Wong, M.G. Bawendi, R.K. Jain, D. Fukumura.Multistage nanoparticles for improved delivery into tumor tissue.Methods in Enzymology.508 (2012), pp. 109-130
46. V. Subr, K. Ulbrich.Synthesis and properties of new N-(2-hydroxypropyl)-methacrylamide copolymers containing thiazolidine-2-thione reactive groups.Reactive and Functional Polymers, 66(12) (2006), pp. 1525-1538
47. W. Tai, R. Mahato, K. Cheng.The role of HER2 in cancer therapy and targeted drug delivery.Journal of Controlled Release, 146(3),(2010), pp. 264-275
48. C.B. Thompson, H.M. Shepard, P.M. O’Connor, S. Kadhim, P. Jiang, R.J. Osgood, L.H. Bookbinder, X. Li, B.J. Sugarman, R.J. Connor, S. Nadjsombati, G.I. Frost.Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models.Mol. Cancer Ther., 9 (2010), pp. 3052-3064
49. D.D. Von Hoff, R.K. Ramanathan, M.J. Borad, D.A. Laheru, L.S. Smith, T.E. Wood, R.L. Korn, N. Desai, V. Trieu, J.L. Iglesias, H. Zhang, P. Soon-Shiong, T. Shi, N.V. Rajeshkumar, A. Maitra, M. Hidalgo.Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.J. Clin. Oncol., 29 (2011), pp. 4548-4554
50. J. Yang, K. Luo, H. Pan, P. Kopeckova, J. Kopecek.Synthesis of biodegradable multiblock copolymers by click coupling of RAFT-generated heterotelechelic PolyHPMA conjugates.React. Funct. Polym., 71 (2011), pp. 294-302
51. Yuan, J., Zhang, H., Kaur, H., Oupicky, D., Peng, F..Synthesis and characterization of theranostic poly(HPMA)-c(RGDyK)-DOTA- 64Cu copolymer targeting tumor angiogenesis: Tumor localization visualized by positron emission tomography. Molecular Imaging., 12 (3) (2011), pp. 294-302
52. B. Zarabi, M.P. Borgman, J. Zhuo, R. Gullapalli, H. Ghandehari Noninvasive monitoring of HPMA copolymer–RGDfK conjugates by magnetic resonance imaging.Pharm. Res., 26 (2009), pp. 1121-1129
53. R. Zhang, K. Luo, J. Yang, M. Sima, M.M. Janát-Amsbury, J. Kopecek.Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel.Journal of Controlled Release, 166(1),(2013), pp. 66-74